BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 10889385)

  • 1. CT-guided
    Yan H; Mo Z; Xiang Z; Rong D; Zhang Y; Chen G; Zhong Z; Zhang F; Gao F
    J Cancer; 2017; 8(11):2104-2113. PubMed ID: 28819412
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of interventional radiotherapy (brachytherapy) in nasopharynx tumors: A systematic review.
    Milazzotto R; Lancellotta V; Posa A; Fionda B; Massaccesi M; Cornacchione P; Spatola C; Kovács G; Morganti AG; Bussu F; Valentini V; Iezzi R; Tagliaferri L
    J Contemp Brachytherapy; 2023 Oct; 15(5):383-390. PubMed ID: 38026072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Sparing in Intensity-Modulated Radiation Therapy of Nasopharyngeal Carcinoma.
    Baba MH; Singh BK; Wani SUQ
    J Med Phys; 2022; 47(3):243-249. PubMed ID: 36684702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma.
    Lin Y; Ouyang Y; Lu Z; Liu Y; Chen K; Cao X
    Front Oncol; 2019; 9():278. PubMed ID: 31134143
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.
    Lee VH; Kwong DL; Leung TW; Ng SC; Lam KO; Tong CC; Sze CK
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1067-1078. PubMed ID: 27738820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes.
    Pham A; Arora S; Wernicke AG; Kutler DI; Cohen M; Kuhel W; Trichter S; Nori D; Formenti SC; Parashar B
    J Contemp Brachytherapy; 2015 Dec; 7(6):445-52. PubMed ID: 26816501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Customized individual applicators for endocavitary brachytherapy in patients with cancers of the nasal cavity, sinonasal region and nasopharynx.
    Kadah BA; Niewald M; Papaspyrou G; Dzierma Y; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1543-7. PubMed ID: 25905695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.
    Kovács G
    J Contemp Brachytherapy; 2015 Jan; 6(4):404-16. PubMed ID: 25834586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.
    Rosenblatt E; Abdel-Wahab M; El-Gantiry M; Elattar I; Bourque JM; Afiane M; Benjaafar N; Abubaker S; Chansilpa Y; Vikram B; Levendag P
    Radiat Oncol; 2014 Mar; 9():67. PubMed ID: 24581393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for head and neck cancer.
    Yeh SA
    Semin Plast Surg; 2010 May; 24(2):127-36. PubMed ID: 22550433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers.
    Tunio MA; Rafi M; Hashmi A; Mohsin R; Qayyum A; Hasan M; Sattar A; Mubarak M
    World J Gastroenterol; 2010 Sep; 16(35):4436-42. PubMed ID: 20845511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.
    Chen Y; Wang XL; Yan ZP; Cheng JM; Wang JH; Gong GQ; Qian S; Luo JJ; Liu QX
    World J Gastroenterol; 2004 Dec; 10(23):3506-10. PubMed ID: 15526374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
    Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial.
    Syed AM; Puthawala AA; Damore SJ; Cherlow JM; Austin PA; Sposto R; Ramsinghani NS
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1311-21. PubMed ID: 10889385
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.